Trial tested approach against antiviral prophylaxis in CMV-seronegative recipients Using preemptive therapy led to a lower incidence of cytomegalovirus (CMV) disease over 12 months in CMV-seronegative liver transplant recipients...
Read MoreAlgorithm helps identify which patients can be offered fertility-sparing treatment options Using the Proactive Molecular Classifier for endometrial cancer (ProMisE) algorithm to classify patients with endometrial cancer or...
Read MoreStudy shows need for identification of high-risk pregnancies and proactive management The risk of non-traumatic intracerebral hemorrhage (ICH) was highest among pregnant women in their third trimester as well as during the first...
Read MoreAnalysis of Medicare Part D coverage, finds affordable access out of sight for some People who are not eligible for low-income subsidies could pay up to a whopping $4,000 out of pocket for HIV medications each year, new...
Read More
Worse prognosis for smokers after primary PCI in STEMI, pooled data shows The...
Read More
Results in shorter times to wound closure and higher closure rates Negative pressure wound therapy...
Read More
Effect seen through six months, but not after Exclusive breast feeding in the first 2 months...
Read More
EAST ST. LOUIS, Ill. — Ethel Sylvester dialed 911, trembling with fear. The 92-year-old felt...
Read More
Terry Smith, a 65-year-old Vietnam veteran with PTSD, multiple health issues and a history of...
Read More
Martha Phillips knows exactly how it feels to suddenly find oneself up close to — and...
Read More
Non-D2-receptor-binding agent resulted in reductions in psychosis, negative symptoms ...
Read More
We know a lot about what we don’t know Five months in, and the shape of the Covid-19...
Read MoreThe first non-surgical treatment option for a rare cancer subtype WASHINGTON — Mitomycin gel (Jelmyto), an alkylating drug, is now FDA-approved as the first non-surgical treatment for low-grade upper tract urothelial...
Read More
But making the list and transplant centers may still be barriers Patients with advanced heart...
Read More
AMA says cutting funding during a pandemic ’is not in the U.S. interests’ President...
Read More
The number of health care workers who have tested positive for the coronavirus is likely far...
Read More
Massachusetts is launching an effort to reach everyone in the state who may have the coronavirus...
Read MoreNon-D2-receptor-binding agent resulted in reductions in psychosis, negative symptoms Treatment with an investigational non-D2-receptor-binding agent led to significant reductions in psychosis and negative symptoms in...
Read MoreWe know a lot about what we don’t know Five months in, and the shape of the Covid-19 pandemic remains elusive, with the lack of clarity extending to what the disease looks like, who has it, who is infectious, who is...
Read MoreThe first non-surgical treatment option for a rare cancer subtype WASHINGTON — Mitomycin gel (Jelmyto), an alkylating drug, is now FDA-approved as the first non-surgical treatment for low-grade upper tract urothelial...
Read More
